Scribe Therapeutics, Inc.

SCTX chart

Scribe Therapeutics, Inc. news

• Scribe Therapeutics (SCTX) Short Interest & Short Float | Updated Oct 2026

  MarketBeat · Oct 26, 9:03 PM EDT

• SCTX News | SCRIBE THERAPEUTICS INC (NASDAQ:SCTX)

  ChartMill · Oct 23, 8:00 PM EDT

• Scribe Therapeutics Inc. Estimates – NASDAQ:SCTX

  TradingView · Oct 23, 2:04 PM EDT

• Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Has Consensus Target Price of $51.75

  MarketBeat · Oct 23, 4:17 AM EDT

• $SCTX stock is down 13% today. Here's what we see in our data.

  Quiver Quantitative · Oct 22, 10:56 AM EDT

• Cathie Wood’s ARK sells Shopify stock, buys Scribe Therapeutics

  Investing.com · Oct 21, 8:18 PM EDT

• Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

  fool.com · Oct 20, 12:50 PM EDT

• Cathie Wood Makes $64 Million Bet on Two Stocks

  Yahoo Finance · Sep 28, 3:11 PM EDT

• Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names

  stocktwits.com · Sep 22, 7:10 AM EDT

• Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout

  Yahoo Finance · Sep 17, 4:09 PM EDT

• Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

  Yahoo Finance · Sep 2, 4:05 PM EDT

• Scribe Therapeutics to Participate in Upcoming Investor Conferences

  Yahoo Finance · Sep 1, 8:00 AM EDT

Scribe Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-09-02
• 8-K8-K2026-09-02
• 8-K8-K2026-07-27
• S-1S-12026-07-02

About Scribe Therapeutics, Inc.

Ticker

SCTX (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Alameda, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1853921

Frequently asked questions